177 related articles for article (PubMed ID: 37855282)
1. Why Pharmacovigilance of Non-steroidal Anti-inflammatory Drugs is Important in India?
Dash S; Singh PA; Bajwa N; Choudhury A; Bisht P; Sharma R
Endocr Metab Immune Disord Drug Targets; 2024; 24(7):731-748. PubMed ID: 37855282
[TBL] [Abstract][Full Text] [Related]
2. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.
Shukla S; Sharma P; Gupta P; Pandey S; Agrawal R; Rathour D; Kumar Kewat D; Singh R; Kumar Thakur S; Paliwal R; Sulakhiya K
Curr Drug Saf; 2024; 19(2):172-190. PubMed ID: 37132145
[TBL] [Abstract][Full Text] [Related]
3. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.
Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
Fundam Clin Pharmacol; 2014 Apr; 28(2):230-5. PubMed ID: 23190210
[TBL] [Abstract][Full Text] [Related]
4. Pharmacovigilance of herbal medicines: Concerns and future prospects.
Choudhury A; Singh PA; Bajwa N; Dash S; Bisht P
J Ethnopharmacol; 2023 Jun; 309():116383. PubMed ID: 36918049
[TBL] [Abstract][Full Text] [Related]
5. Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System.
Monteiro C; Silvestre S; Duarte AP; Alves G
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329224
[TBL] [Abstract][Full Text] [Related]
6. Retrospective pharmacovigilance analysis of nonsteroidal anti-inflammatory drugs-induced chronic kidney disease.
Swathi VS; Saroha S; Prakash J; Bhushan S
Indian J Pharmacol; 2021; 53(3):192-197. PubMed ID: 34169903
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.
Eccleston C; Cooper TE; Fisher E; Anderson B; Wilkinson NM
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012537. PubMed ID: 28770976
[TBL] [Abstract][Full Text] [Related]
8. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
[TBL] [Abstract][Full Text] [Related]
9. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006.
Lapeyre-Mestre M; Grolleau S; Montastruc JL;
Fundam Clin Pharmacol; 2013 Apr; 27(2):223-30. PubMed ID: 21929527
[TBL] [Abstract][Full Text] [Related]
11. Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017.
Bukic J; Rusic D; Mas P; Karabatic D; Bozic J; Seselja Perisin A; Leskur D; Krnic D; Tomic S; Modun D
BMC Pharmacol Toxicol; 2019 Oct; 20(1):60. PubMed ID: 31627740
[TBL] [Abstract][Full Text] [Related]
12. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
[TBL] [Abstract][Full Text] [Related]
13. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
14. Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system.
Rafaniello C; Ferrajolo C; Sullo MG; Sessa M; Sportiello L; Balzano A; Manguso F; Aiezza ML; Rossi F; Scarpignato C; Capuano A
Pharmacol Res; 2016 Feb; 104():108-14. PubMed ID: 26739516
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of adverse drug reactions due to nonsteroidal anti-inflammatory drugs: a cross-sectional study.
Sonsupap C; Pokhakul P; Kariya T; Suzuki Y; Hamajima N; Yamamoto E
Nagoya J Med Sci; 2023 Nov; 85(4):668-681. PubMed ID: 38155619
[TBL] [Abstract][Full Text] [Related]
16. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
17. Indirect and Direct 65+ Patient Reporting of Non-Steroidal Anti-Inflammatory Drug-Induced Adverse Drug Reactions as a Source of Information on Polypharmacy and Polypharmacy-Related Risk.
Sienkiewicz K; Burzyńska M; Rydlewska-Liszkowska I; Sienkiewicz J; Gaszyńska E
Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763704
[No Abstract] [Full Text] [Related]
18. Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations.
Figueras A; Capellà D; Castel JM; Laorte JR
Eur J Clin Pharmacol; 1994; 47(4):297-303. PubMed ID: 7875178
[TBL] [Abstract][Full Text] [Related]
19. Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand.
Phueanpinit P; Jarernsiripornkul N; Pongwecharak J; Krska J
Int J Clin Pharm; 2014 Dec; 36(6):1205-12. PubMed ID: 25288144
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
